Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

November UNC Health System Pharmacy Resident CE Series (Home Studies)


CE Hours

3.00

CE Units

0.300

Activity Type

  • Knowledge

Accreditation(s)

Participants have 60 days from the start of their program to claim CE credit and verify it has been upload to CPE Monitor. If your program requires the completion of a post test/eval/survey those items MUST be done before that 60 day window closes to receive credit for that program. Statements of credit can be viewed and printed from CPE Monitor. Statements of credit will no longer be printed and mailed to the participant. **No partial individual session credit will be given**
 
PAYMENT NOTE: During the registration process, if a fee is required, please enter the zip code associated with your credit card's BILLING ADDRESS. For security purposes payments are processed through a separate system, so when prompted, please click “ok” to be taken to that site and complete your registration. Upon successful registration of this program you will receive an email confirmation/receipt and will be returned to this program page. When you are retuned to this page you will see a note at the top of the page reading “You are registered for this program.”
If you are not automatically returned to this page or see only a blank white screen your transaction was not successful, and you will need to try again.

 

If paying by check please mail to the address below:

UNC Eshelman School of Pharmacy
Attn: Continuing Education
301 Pharmacy Lane, CB# 7574 Beard Hall
Chapel Hill, NC 27599
 
 
Accreditation Council for Pharmacy Education
The University of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. To receive CE credit, participants must complete the CE attendance form and the online evaluation of the program (instructions to be emailed). Statements of credit can be viewed and printed in CPE Monitor approximately 2 to 3 weeks after the program and you have completed any needed requirements. **No partial credit will be available**

Co-Sponsor(s)

UNC Health System

Support/Credits

 
Cancelations: Cancelations must be received in writing/email to the Office of Continuing Education at least 48 hours prior to start date to receive a full refund. No refunds will be given within 48 hours of the start date.
 
 
IMPORTANT: UNC HEALTH SYSTEM EMPLOYEES AND UNC ESHELMAN SCHOOL OF PHARMACY STUDENTS ONLY
 
UNC Health System Employees and ESOP Students are able to attend this Resident Series at no charge to them. If you are a Health System Employee or Student please follow the steps below. This only applies to this series. Other UNC ESOP CE programs are available to register at the fee listed on that page.
  1. UNC Health System Employees and UNC ESOP Students should register using your UNC email address. UNC Employees - please select your employment location during the registration process. UNC Students - please respond "Yes" to the "Are you a UNC Student" question.
  2. Select the “Check” payment method on the registration page. Your employment will be verified prior to credit being uploaded
Program Materials: A link to the program recording and presentation slides will be found under the session by expanding the module after completing registration. Once the content has been completed return to this page to complete the post assessment and evaluation. After those have been submitted your credit will automattically be uploaded to CPE Monitor.

 

 

   

This session will provide pharmacists up to date literature surrounding treatment approaches to antiplatelet deescalation strategies in patients with coronary artery disease. De-escalation approaches reviewed will include duration, dose, and P2Y12 agent selection. This presentaiton will also critically evaluate patient specific ischemic and bleeding risk factors. This presentation will allow pharmacists to provide individualized care for each patient, improving outcomes associated with this disease state.

Presentation Slides available for download at the bottom of this module. You MUST be signed into your registered account to access this content

Objectives

  • Define the role of de-escalation of dual antiplatelet therapy in patients with coronary artery disease
  • Assemble a checklist of patient characteristics to evaluate in selecting a dual antiplatelet therapy de escalation strategy.
  • Describe current literature on de-escalation approaches to dual antiplatelet therapy including shortening duration, agent selection, and P2Y12 inhibitor dose reductions.
  • Produce a de-escalated antiplatelet strategy for an individual patient with coronary artery disease.

Speaker(s)/Author(s)

Madeline Fuller, PharmD
PGY-1 Pharmacy Resident

Activity Number

0046-9999-21-265-H01-P

Release Date: Nov 4, 2021
Credit Expiration Date: Nov 4, 2022

CE Hours

1.00

Fee

$10.00
   

   

Heart Failure with Preserved Ejection Fraction (HFpEF) has limited evidence to guide it's management. Recent publications and reviews of subgroup analyses from previous trials, may help to change the way HFpEF is clinically managed. This presentation will discuss the current management of HFpEF, evaluate the literature surrounding the treatment of HFpEF, and predict future directions in HFpEF management. Therefore, this presentation will lead to better patient care for those experiencing HFpEF.
 

Objectives

  • Define the most current classification of heart failure according to recently published guidance documents
  • Analyze existing guidelines and literature supporting the pharmacologic management of HFpEf
  • Explain the pathophysiology of heart failure with a specific focus on preserved ejection fraction
  • Examine a HFpEF treatment strategy incorporating newer evidence and evolving understanding of the role of the EF

Speaker(s)/Author(s)

Kaitlin Musick, PharmD
PGY1 Acute Care Pharmacy Resident

Activity Number

0046-9999-21-274-H01-P

Release Date: Nov 11, 2021
Credit Expiration Date: Nov 11, 2022

CE Hours

1.00

Fee

$10.00
   

   

The disease state of hemophagocytic lymphohistocytosis is complex and must be carefully evaluated to ensure appropriate treatment is delivered. This is especially true in pediatric patients, where a myriad of genetic components can make this condition fatal. It is vital for pharmacists to be able to evaluate a patient presenting with HLH and implement quality immunosuppressive therapy in a timely fashion to ensure that patient outcomes are optimized.

Objectives

  • Discuss underlying pathophysiology of hemophagocytic lymphohistiocytosis (HLH)
  • Summarize the updated diagnostic criteria for HLH
  • Recognize the various types of HLH seen in pediatric patients
  • Outline current treatment options for pediatric HLH

Speaker(s)/Author(s)

Ryan Sutherlan, PharmD
PGY2 Pediatric Pharmacy Resident

Activity Number

0046-9999-21-276-H01-P

Release Date: Nov 18, 2021
Credit Expiration Date: Nov 18, 2022

CE Hours

1.00

Fee

$10.00